The global microfluidics market was valued at USD 26.45 billion in 2022 and it is predicted to surpass around USD 83.61 billion by 2032 with a CAGR of 12.2% from 2023 to 2032.
Key Pointers
Report Coverage | Details |
Market Size in 2022 | USD 26.45 billion |
Revenue Forecast by 2032 | USD 83.61 billion |
Growth rate from 2023 to 2032 | CAGR of 12.2% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Illumina, Inc.; F. Hoffmann-La Roche Ltd; PerkinElmer, Inc; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Danaher Corporation; Abbott; Standard BioTools |
The increasing penetration of microfluidics devices in various fields of research and diagnosis is expected to drive the market. For instance, there has been an improvement in the number of microfluidic devices applicable to ophthalmological conditions over the past decade. Microfluidic approaches have been effectively used to determine glucose levels, detect infection, diagnose dry eye disease, and assess levels of vascular endothelium growth factor. Such applications are expected to positively affect the microfluidics market growth in the coming years.
For instance, BeforCure, a spin-off company from Elvesys, developed an ultra-fast PCR-on-chip system for the detection of the virus. This product is based on Fastgen technology and leverages the advantages of microfluidics to deliver test results in less than 30 minutes. Furthermore, various studies are being conducted to evaluate the use of microfluidics in COVID-19 detection by PCR technique. A study was published in June 2021 by researchers in China that demonstrated the use of the latest rapid microfluidic PCR. It concluded that rapid PCR can be achieved with the use of emerging state-of-the-art microfluidics for SARS-CoV-2 detection.
The major advantage of microfluidics devices is their ability to analyze small volumes of samples. This reduces the amount of reagent waste and helps preserve samples that are difficult to produce. The introduction of microfluidics devices has driven the demand for low-volume sample devices. A surge in research activities undertaken by analytical and clinical researchers has also driven the demand for microfluidics devices. The conventional method of genome analysis requires decoding the entire DNA, thus adding to the cost of analysis and time. Microfluidics devices need a very small volume of samples for data interpretation. The application of microfluidics has allowed conventional laboratory procedures to be miniaturized onto a lab-on-a-chip.
The point-of-care diagnostics introduced by numerous market players led to early disease diagnosis and reduced hospital visits. With improved technologies, market players now distinguish their products using minimally invasive features along with accuracy and speed. Microfluidics has thus made its mark in the IVD market. Moreover, market players, such as Abbott, Roche, and Danaher, have already incorporated microfluidics technology in their existing diagnostic devices. With advancements in technology, digital microfluidics is being explored by several key players. In August 2022, HORIBA announced a collaboration with SigTuple to speed up the deployment of its AI100, an AI-assisted digital pathology solution, in the Indian subcontinent. SigTuple combined AI, robotics, microfluidics, and cloud computing to develop smart diagnostic solutions to make quality healthcare delivery accessible and affordable.
Microfluidics Market Segmentations:
By Technology
By Material
By Application
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Microfluidics Market
5.1. COVID-19 Landscape: Microfluidics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Microfluidics Market, By Technology
8.1. Microfluidics Market, by Technology, 2023-2032
8.1.1 Medical/Healthcare
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Non-medical
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Microfluidics Market, By Material
9.1. Microfluidics Market, by Material, 2023-2032
9.1.1. Silicon
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Glass
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Polymer
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. PDMS
9.1.4.1. Market Revenue and Forecast (2019-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Microfluidics Market, By Application
10.1. Microfluidics Market, by Application, 2023-2032
10.1.1. Lab-on-a-chip
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Organs-on-chips
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Continuous Flow Microfluidics
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Optofluidics And Microfluidics
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Acoustofluidics And Microfluidics
10.1.5.1. Market Revenue and Forecast (2019-2032)
10.1.6. Electrophoresis And Microfluidics
10.1.6.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Microfluidics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Technology (2019-2032)
11.1.2. Market Revenue and Forecast, by Material (2019-2032)
11.1.3. Market Revenue and Forecast, by Application (2019-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.1.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.1.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.1.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.1.5.3. Market Revenue and Forecast, by Application (2019-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Technology (2019-2032)
11.2.2. Market Revenue and Forecast, by Material (2019-2032)
11.2.3. Market Revenue and Forecast, by Application (2019-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.2.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.2.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.2.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.2.5.3. Market Revenue and Forecast, by Application (2019-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Technology (2019-2032)
11.2.6.2. Market Revenue and Forecast, by Material (2019-2032)
11.2.6.3. Market Revenue and Forecast, by Application (2019-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Technology (2019-2032)
11.2.7.2. Market Revenue and Forecast, by Material (2019-2032)
11.2.7.3. Market Revenue and Forecast, by Application (2019-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Technology (2019-2032)
11.3.2. Market Revenue and Forecast, by Material (2019-2032)
11.3.3. Market Revenue and Forecast, by Application (2019-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.3.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.3.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.3.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.3.5.3. Market Revenue and Forecast, by Application (2019-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Technology (2019-2032)
11.3.6.2. Market Revenue and Forecast, by Material (2019-2032)
11.3.6.3. Market Revenue and Forecast, by Application (2019-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Technology (2019-2032)
11.3.7.2. Market Revenue and Forecast, by Material (2019-2032)
11.3.7.3. Market Revenue and Forecast, by Application (2019-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.4.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.4.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.4.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.4.5.3. Market Revenue and Forecast, by Application (2019-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Technology (2019-2032)
11.4.6.2. Market Revenue and Forecast, by Material (2019-2032)
11.4.6.3. Market Revenue and Forecast, by Application (2019-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Technology (2019-2032)
11.4.7.2. Market Revenue and Forecast, by Material (2019-2032)
11.4.7.3. Market Revenue and Forecast, by Application (2019-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.5.3. Market Revenue and Forecast, by Application (2019-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Technology (2019-2032)
11.5.4.2. Market Revenue and Forecast, by Material (2019-2032)
11.5.4.3. Market Revenue and Forecast, by Application (2019-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Technology (2019-2032)
11.5.5.2. Market Revenue and Forecast, by Material (2019-2032)
11.5.5.3. Market Revenue and Forecast, by Application (2019-2032)
Chapter 12. Company Profiles
12.1. Illumina, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. F. Hoffmann-La Roche Ltd
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. PerkinElmer, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Agilent Technologies, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danaher Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Abbott
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Standard BioTools
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms